What is CCSVI
Some studies have indicated that a phenomenon called CCSVI (chronic cerebrospinal venous insufficiency), a reported abnormality in blood drainage from the brain and spinal cord, may contribute to nervous system damage in MS. This hypothesis was put forth by Dr. Paolo Zamboni from the University of Ferrara in Italy in 2009, and is now being pursued by other investigators as well.
CCSVI Research
The Society shares in the public urgency to advance the understanding of CCSVI as quickly as possible. In order to pursue this lead in MS, the National MS Society collaborated with the MS Society of Canada in 2009 to fund seven research projects.
- Global research efforts on CCSVI
- Progress reports from Society-funded CCSVI research projects
- CCVSI Funding FAQ
What’s New
- National MS Society: Latest results about emerging MS therapies, risk factors, disease mechanisms, rehabilitation, CCSVI, and much more presented at AAN Meeting (May 2012)
- ABC News: FDA Issues Warning About Experimental MS Therapy (May 2012)
- National MS Society: FDA Issues Safety Communication About Procedures to Treat CCSVI in People with MS (May 2012)
- National MS Society: Canadian Government Chooses Research Team to Conduct Clinical Trial to Treat CCSVI (April 2012)
- Read more CCSVI in the news
Direct feed of latest published CCSVI research results from the National Library of Medicine's PubMed